Awantia
European procurement intelligence
Search
Expiry radar
Sign in
de
Awarded
Bekanntmachung vergebener Aufträge nach §130 c SGB V zu dem Arzneimittel Colchicin (Colxi)
Buyer
GWQ ServicePlus AG
Winners
APONTIS PHARMA Deutschland GmbH & Co. KG
Contract value
€1
Bids received
1
Published
31 Mar 2026
Contract start
1 Apr 2026
Contract end
31 Mar 2028
stated
Sector
Medical equipment and pharmaceuticals
Region
Nordrhein-Westfalen (DEA11)
Source
Original notice on TED (223232-2026)
More awards from this buyer
Awarded
Buyer
Winner
Contract value
Published
Valganciclovir (FTA)
GWQ ServicePlus AG
Amarox Pharma GmbH
,
PUREN Pharma GmbH & Co. KG
,
Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg
—
11 Aug 2026
Ticagrelor (FTA)
GWQ ServicePlus AG
089Pharm GmbH
,
Ascend GmbH
,
Zentiva Pharma GmbH
—
11 Aug 2026
Temozolomid (HKP)
GWQ ServicePlus AG
Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH
,
Fairmed Healthcare GmbH
,
medac GmbH
—
11 Aug 2026
Telmisartan + HCT (TAB, FTA)
GWQ ServicePlus AG
BG Heumann / Heunet GbR
,
Micro Labs GmbH
,
Zentiva Pharma GmbH
—
11 Aug 2026
Telmisartan (TAB, FTA)
GWQ ServicePlus AG
Medical Valley Invest AB
,
Micro Labs GmbH
,
Zentiva Pharma GmbH
—
11 Aug 2026
Tapentadol (RET)
GWQ ServicePlus AG
BG ALIUD / STADAPHARM GbR
,
G.L. Pharma Deutschland GmbH
,
Micro Labs GmbH
—
11 Aug 2026